|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/68 | |
| G01N 33/574 | |||
| A61K 35/17 | |||
| A61P 35/00 |
| (11) | Number of the document | 3384052 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16871163.8 |
| Date of filing the European patent application | 2016-09-09 | |
| (97) | Date of publication of the European application | 2018-10-10 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/SG2016/050441 |
| Date | 2016-09-09 |
| (87) | Number | WO 2017/095324 |
| Date | 2017-06-08 |
| (30) | Number | Date | Country code |
| 10201509979S | 2015-12-04 | SG |
| (72) |
CONNOLLY, John, SG
HOPKINS, Richard, SG
TOH, Han Chong, SG
|
| (73) |
Agency for Science, Technology and Research,
1 Fusionopolis Way 20-10, Connexis North Tower, Singapore 138632,
SG
Tessa Therapeutics Ltd., 8 Temasek Boulevard No.24-02, Suntec Tower Three, Singapore 038988, SG Singapore Health Services Pte. Ltd., 31 Third Hospital Avenue No.03-03 Bowyer Block C, Singapore 168753, SG |
| (54) | CLINICAL CORRELATES OF IMMUNOTHERAPY EFFICACY |
| CLINICAL CORRELATES OF IMMUNOTHERAPY EFFICACY |